Anixa Biosciences, Inc.
ANIX
$2.66
-$0.03-1.12%
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.19% | -27.96% | -16.65% | -7.04% | 11.12% |
| Total Depreciation and Amortization | -31.25% | -19.57% | -11.11% | 9.09% | 11.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.58% | 0.87% | 6.71% | 0.23% | -9.30% |
| Change in Net Operating Assets | 148.91% | 149.62% | -736.05% | -333.51% | -19.04% |
| Cash from Operations | -21.44% | -18.13% | -43.61% | -24.12% | 10.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 240.14% | 176.33% | 118.87% | 94.73% | 62.87% |
| Cash from Investing | 240.14% | 176.33% | 118.87% | 94.73% | 62.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 175.58% | 242.08% | 1,659.77% | 46.77% | -48.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.77% | -- | -- | -- | -- |
| Cash from Financing | -56.78% | 833.06% | 1,308.08% | 550.66% | 477.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.63% | 103.11% | 90.63% | 79.08% | 56.02% |
